Authors
Latest:
A Diabetes Success StoryOne of the most enduring lessons from my training in the care of geriatric patients is the following maxim: “Treat every new symptom like a (possible) drug adverse effect until proven otherwise.”
Latest:
A Tribute to Oncology NursesOncology nurses help improve patient outcomes through their dedication and expertise.
Latest:
Taking Medication in Diabetes Self-Management: Issues and Recommendations for Reducing BarriersThis paper considers opportunities and barriers relating to medication taking and self-management by people with diabetes and related conditions as discussed during an invitational symposium.
Latest:
Depression and Breast-Feeding: Medication UseKnowledgeable pharmacists can positively influence mothers who are depressed as well as women who want to breast-feed but do not because of medication use.
Latest:
Rethinking Pharmacy Employee EngagementWhile often overlooked, employee engagement is a key element in determining whether a hospital, health system, or pharmacy service can effectively meet its patient access, patient quality, and organizational financial demands.
Latest:
Laser Focused in Drug UsageA model of formulary decision making that evaluates medications based on usage could have significant implications for providers, consumers, and manufacturers.
Latest:
Decongestants and Hypertension: Dangerous TogetherNearly 33% of adults in the United States have the typically symptomless disease known as hypertension.
Latest:
Trends Associated with Implementing and Lifting a Pregabalin Step Therapy PolicyThis study examined the impact of a pregabalin step therapy policy on utilization and medical costs in Humana’s Medicare and commercial plans.
Latest:
Continuous Glucose Monitoring: An Opportunity to Understand and Individualize Diabetes ManagementFor patients with diabetes, continuous glucose monitoring offers the opportunity to lessen the burden of traditional finger sticks.
Latest:
Comparative Treatment Patterns Among Psoriasis Patients Using Adalimumab, Etanercept, or UstekinumabThis retrospective study compared the treatment patterns of ustekinumab with recommended maintenance administration every 12 weeks, with adalimumab and etanercept, administered weekly or every other week, for the treatment of plaque psoriasis.
Latest:
Comparative Effectiveness of Fidaxomicin for Treatment of Clostridium Difficile InfectionOur analysis models the clinical and economic value of fidaxomicin for the treatment of Clostridium difficile infection compared with metronidazole and vancomycin.
Latest:
Shionogi Pharma's KapvayThe FDA approved Kapvay (clonidine hydrochloride extended -release) as a monotherapy and adjunctive therapy for the treatment of attention- deficit/hyperactivity disorder in children and adolescents aged 6 to 17 years.
Latest:
Contribution of Phone Follow-up to Improved Adherence to Oral Osteoporosis TreatmentThe authors studied the usefulness of a regular telephone follow-up to improve adherence to oral antiosteoporosis treatments. Their results support such follow-up and the use of this strategy in routine clinical practice.
Latest:
The Down and Dirty on Sexually Transmitted DiseasesSexually transmitted diseases (STDs) can be silent destructors. Patients may be unknowingly spreading infections or afraid to discuss them due to their sensitive nature.
Latest:
Cost Implications of Early Treatment Initiation Among Patients With Newly Diagnosed FibromyalgiaInitiation of treatment with guideline-recommended medications within 60 days of fibromyalgia diagnosis was associated with immediate annual healthcare cost savings.
Latest:
First-in-Class Approved Anti-BCMA Therapy: Belantamab Mafodotin-blmfBelantamab mafodotin-blmf (Blenrep; GlaxoSmithKline) is the first in its class anti-BCMA therapy to gain FDA approval.
Latest:
Counseling Tips for Patients with Irritable Bowel SyndromePatients with irritable bowel syndrome-like symptoms often seek advice about the use of OTC medications. The pharmacist should determine if self-treatment is appropriate.
Latest:
Clinical Insights: Use of Combination Therapy for Advanced Clear-Cell Renal Cell CarcinomaApproximately 73,000 NEW cases of renal cell carcinoma (RCC) are expected to be diagnosed in 2019 in the United States, with up to 70% of these cases anticipated to be clear-cell subtype.
Latest:
Factors Associated With Employee Participation in a Value-Based Insurance Design InitiativeWe describe enrollment in a voluntary VBID initiative. Uptake was suboptimal, suggesting that barriers to enrollment may have significant implications for the overall effectiveness of VBID.
Latest:
Cost Impact of Switching From Metoprolol to Nebivolol for HypertensionA large single-payer administrative claims database was used to assess the economic impact of switching from metoprolol to nebivolol for the treatment of hypertension.
Latest:
Guidelines for Collaboration Among Physicians, Pharmacists, and Managed Care Organizations to Improve Asthma OutcomesNew ideas, new tools, and new collaborations among managed care, physicians, and pharmacy to optimize value in asthma management.
Latest:
Systemic Therapy Options for Treating HR+/HER2– Metastatic Breast CancerFollowing initial breast cancer diagnosis by mammography, MRI, or ultrasound, treatment is largely based upon the histologic subtype and staging of the tumor(s).
Latest:
Part D Plans and PBMs Face New Reporting RequirementsA rule from CMS requires, in part, that Medicare Advantage organizations and Medicare Part D plan sponsors have the ability to obtain data.
Latest:
Role of Live-JSLM in Treating Recurrent CDIJoseph Reilly, BS, PharmD, BCGP, and Andrew Skinner, MD, discuss the potential benefits of using live-jslm early on to treat CDI, as well as the implications of this new treatment.
